This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Asch, M. Articles by Gloviczki, P. Search for Related Content PubMed Articles by Asch, M. Articles by Gloviczki, P. Social Bookmarking                         What's this?

The Management of Chronic Venous Ulcers and the Benefit of Subfascial Endoscopic Perforator Vein Surgery

Vascular and Interventional Radiology, Mount Sinai Hospital and University Health Network, University of Toronto, Ontario, Canada

Peter G. Kalman, M.D.

Toronto East General Hospital, Division of Vascular Surgery, The University of Toronto, Toronto, Ontario, Canada

Gregory L. Moneta, M.D.

Division of Vascular Surgery, Department of Surgery, Oregon Health Sciences University, Portland, OR

Peter Gloviczki, M.D.

Mayo Medical School; Chair, Division of Vascular Surgery, Mayo Clinic, Rochester, MN

Elastic compression is the primary treatment modality of venous ulcers. Local ulcer treatment is important to enhance granulation and prevent or treat infection, while surgical treatment is aimed at correcting the underlying venous stasis and ambulatory venous hypertension. This debate reviews the pros and cons of surgical treatment for venous incompetence and discusses current evidence to support the use of subfascial endoscopic perforator vein surgery (SEPS). Ablation of superficial reflux with high ligation and stripping of the incompetent saphenous vein, done together with avulsion of varicose veins, remains the main surgical treatment of chronic venous insufficiency. Level 1 evidence of clinical and hemodynamic improvement directly related to interruption of incompetent perforators is currently not available. The North American SEPS registry experience and reports from larger centers, however, provide data on rapid ulcer healing, low morbidity, and decreased wound complications from endoscopic perforator interruption. SEPS, together with ablation of the superficial reflux, when present, can be offered to surgical candidates with advanced chronic venous insufficiency and venous ulcers. While improvement in post-thrombotic patients may be modest, those with primary valvular incompetence will have a predictably good clinical outcome and improved hemodynamic results. The superiority of surgical treatment over optimal medical management remains to be established in a prospective randomized, multi-center trial. The North American Venous Ulcer Surgery (NAVUS) Trial has been designed to answer the role of ablation of the superficial reflux, with or without SEPS, in the treatment of venous ulcers.

Key Words: Venous ulcers • surgery • perforating veins • endoscopy SEPS

Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 13, No. 2, 103-117 (2000)
DOI: 10.1177/153100350001300216


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?